Evaluation of Local Anesthetic Diffusion to the Sciatic Nerve During Adductor Canal Block (DiffuCAdd)

December 10, 2025 updated by: Assistance Publique - Hôpitaux de Paris

Evaluation of Local Anesthetic Diffusion to the Sciatic Nerve During Adductor Canal Block: an Observational Study

Adductor canal block is an effective analgesic technique for major knee surgery. However, the saphenous nerve block is not sufficient to explain this block's efficiency. It has been shown that adductor canal block can spread to the tibial and fibular nerves through the adductor hiatus. However, this diffusion's frequency has never been measured. The main objective of this study is to assess clinically the frequency of the spread of the adductor canal block to the fibular and tibial nerves.

Study Overview

Status

Recruiting

Detailed Description

Adductor canal block is an effective analgesic technique for major knee surgery. The PROSPECT group recommends this block in first intention for locoregional anesthesia in total knee arthroplasty. It has been shown to not be inferior to femoral nerve block in this indication.

The adductor canal block targets the saphenous nerve and, through its spread in the adductor canal, the posterior branch of obturator nerve and the vastus medialis nerve. However, these nerves can't fully explain this block's efficiency.

It has been shown that local anesthetic can spread in the adductor canal to the tibial and fibular nerves through the adductor hiatus. However, this spread is inconstant, and no study has evaluated the frequency of this spread yet.

The main objective of this study is to assess the diffusion's frequency of adductor canal block to fibular and tibial nerves through clinical sensorimotor testing.

Study Type

Observational

Enrollment (Estimated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Boulogne-Billancourt, France, 92100
        • Recruiting
        • Department of Anesthésia, CHU Raymond Poincaré - APHP

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population will be all the consecutive patients scheduled for elective knee surgery under general anesthesia in our center and receiving an adductor canal block.

Description

Inclusion Criteria:

  • patients over 18 years old scheduled for elective knee surgery under general anesthesia
  • in our center
  • receiving an adductor canal block

Exclusion Criteria:

  • patients cognitively impaired,
  • patients suffering from peripheral neuropathy at the lower limb,
  • patients receiving an IPACK block or surgical knee infiltration to complete the adductor canal block analgesia.
  • patients who refused to take part in this study
  • pregnant or breastfeeding patients
  • patients under guardianship
  • imprisoned patients,
  • patients without any medical insurance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of local anesthetic's spread to tibial and fibular nerve
Time Frame: at 4 hours

The primary outcome is the frequency of local anesthetic's spread to tibial and fibular nerve during an adductor canal block, assessed by sensory and motor testing of these nerve territories.

Sensorimotor testing will be performed at four hours with loco-regional anaesthesia.

at 4 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of reduction of sensitivity to cold or touch or reduction in MRC score
Time Frame: at 1 hour and at 4 hours
Frequency of reduction of sensitivity to cold or touch or reduction in MRC score in fibular and tibial nerves territories assessed at one and four hours after the adductor canal block has been performed, as well as reduction of sensitivity to cold or touch in saphenous nerve territory assessed at one and four hours after nerve block.
at 1 hour and at 4 hours
Spread of the local anesthetic in the popliteal fossa
Time Frame: at baseline
Qualitative assessment of local anaesthetic spread in the popliteal fossa on ultrasound recording (spread or no spread).
at baseline
Evaluation of the positive and negative predictive value
Time Frame: at baseline and 1 hour, 4 hours
Evaluation of the positive and negative predictive value, sensitivity and specificity, and positive and negative likelihood ratio of ultrasound-visualised diffusion to the tibial and fibular nerves as a predictive test for clinical impairment of the sensitivity and motor function of these nerves at 1 hour or 4 hours
at baseline and 1 hour, 4 hours
Clinical alteration assessement
Time Frame: at Baseline and at 1 hour and 4 hours
Clinical alteration of sensibility and motricity will be assessed before the adductor canal block is performed and then at H1 and H4. The ultrasound scan of the popliteal fossa will be performed at the same time as the local anaesthetic is administered.
at Baseline and at 1 hour and 4 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Romuald Henry, MD, CHU Raymond Poincaré - APHP

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 10, 2025

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

November 18, 2025

First Submitted That Met QC Criteria

December 10, 2025

First Posted (Actual)

December 24, 2025

Study Record Updates

Last Update Posted (Actual)

December 24, 2025

Last Update Submitted That Met QC Criteria

December 10, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • APHP250730
  • 2025-A00945-44 (Registry Identifier: IDRCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sciatic Nerve

Subscribe